News
Important Only
BRIEF-Metalpha Announces Joint Venture With Abu Dhabi Based Gewan Holding And Subsidiary Of Standard Chartered Zodia Markets
Feb 10 (Reuters) - Metalpha Technology Holding MATH.O:METALPHA ANNOUNCES JOINT VENTURE WITH ABU DHABI BASED GEWAN HOLDING AND SUBSIDIARY OF STANDARD CHARTERED ZODIA MARKETS TO EXPAND INTO THE MIDDLE EAST DIGITAL ASSET MARKETSource text: ID:nPn6MjR21aFurther company coverage: MATH.OReuters
Mon, Feb 10
BRIEF-Hoth Therapeutics Partners With Ontargetx Research And Development
Feb 10 (Reuters) - Hoth Therapeutics HOTH.O:HOTH THERAPEUTICS PARTNERS WITH ONTARGETX RESEARCH AND DEVELOPMENT TO ADVANCE RESEARCH FOR CANCER FIGHTING HT-KIT CANCER THERAPEUTICSource text: ID:nPn20JbKpaFurther company coverage: HOTH.OReuters
Mon, Feb 10
BRIEF-Piraeus Agrees To Enter Into Exclusive Discussions With CVC Regarding The Acquisition Of Ethniki Insurance
Feb 10 (Reuters) - Piraeus Financial Holdings BOPr.AT:PIRAEUS AGREES TO ENTER INTO EXCLUSIVE DISCUSSIONS WITH CVC REGARDING THE ACQUISITION OF ETHNIKI INSURANCEPIRAEUS FINANCIAL HOLDINGS SA - TO POTENTIAL ACQUISITION OF 70% STAKE IN ETHNIKI INSURANCE FOR €469MNSource text: ID:nPnp0BbKaFurther compa...Reuters
Mon, Feb 10
FACTBOX-Modi's US visit raises industry hopes amid tariff threats
By Manoj Kumar NEW DELHI, Feb 10 (Reuters) - Indian Prime Minister Narendra Modi, on a two-day U.S. visit starting Wednesday, is expected to propose tariff cuts and increased energy and defence imports during a meeting with U.S. President Donald Trump. Modi is keen to avert a potential tra...Reuters
Mon, Feb 10
Russia warns outlook for extending last nuclear arms pact with US does not look promising
Last nuclear pact due to expire in less than a year It caps number of warheads Russia and US can deployTrump has spoken about talks with Russia and ChinaMoscow wants Britain and France to be included too Recasts, adds Ryabkov quotes, contextBy Dmitry Antonov and Andrew Osborn MOSCOW, Feb 10 (Re...Reuters
Mon, Feb 10
BRIEF-Innoviz Announces Pricing Of $40 Million Registered Direct Offering
Feb 10 (Reuters) - Innoviz Technologies INVZ.O:INNOVIZ ANNOUNCES PRICING OF $40 MILLION REGISTERED DIRECT OFFERINGINNOVIZ TECHNOLOGIES LTD - ANNOUNCES SECURITIES PURCHASE AGREEMENT FOR 28.8 MILLION UNITS AT $1.39 PER UNITSource text: ID:nPnZtxzYaFurther company coverage: INVZ.OReuters
Mon, Feb 10
BRIEF-Advancell Enters Into Strategic Collaboration With Lilly To Advance Therapies For The Treatment Of Cancer
Feb 10 (Reuters) - Eli Lilly LLY.N:ADVANCELL ENTERS INTO STRATEGIC COLLABORATION WITH LILLY TO ADVANCE NOVEL TARGETED ALPHA THERAPIES FOR THE TREATMENT OF CANCERADVANCELL: TO EXPLORE THE POTENTIAL OF PB-212-BASED ALPHA THERAPIES WITH LILLYFurther company coverage: LLY.NReuters
Mon, Feb 10
TREASURIES-Yields hold steady; traders puzzled by Trump 'fraud' remarks
LONDON, Feb 10 (Reuters) - U.S. Treasury yields traded steadily on Monday, shrugging off remarks over the weekend from President Donald Trump that his administration could look into Treasury debt payments for evidence of possible fraud.Trump, who was speaking to reporters aboard Air Force One on Sun...Reuters
Mon, Feb 10
BRIEF-Global Telesat And Everywhere Communications Announce Partnership To Expand Satellite And IOT Connectivity For European Enterprises And Government Agencies
Feb 10 (Reuters) - NextPlat Corp NXPL.O:GLOBAL TELESAT AND EVERYWHERE COMMUNICATIONS ANNOUNCE PARTNERSHIP TO EXPAND SATELLITE AND IOT CONNECTIVITY FOR EUROPEAN ENTERPRISES AND GOVERNMENT AGENCIESSource text: ID:nPn5zvyW5aFurther company coverage: NXPL.OReuters
Mon, Feb 10
BRIEF-Immune Response Data For INO-3107 To Be Presented As A Poster At American Association For Cancer Research Immuno-Oncology Conference
Feb 10 (Reuters) - Inovio Pharmaceuticals INO.O:IMMUNE RESPONSE DATA FOR INO-3107 TO BE PRESENTED AS A POSTER AT AMERICAN ASSOCIATION FOR CANCER RESEARCH IMMUNO-ONCOLOGY (AACR-IO) CONFERENCESource text: ID:nPn982gS2aFurther company coverage: INO.OReuters
Mon, Feb 10
Golf-The Open becomes second major to create LIV Golf exemption
Feb 10 (Reuters) - The R&A has created an exemption category for LIV Golf players to compete in The Open, it said on Monday, becoming the second major golf tournament to introduce a formal pathway for golfers on the Saudi-backed circuit after the U.S. Open.The leading player not already exempt i...Reuters
Mon, Feb 10
BRIEF-Atlas Engineered Products Provides Update On Operations
Feb 10 (Reuters) - Atlas Engineered Products AEP.V:ATLAS ENGINEERED PRODUCTS PROVIDES UPDATE ON OPERATIONS, TARIFF EXPOSURE AND POSITIVE TRENDS TO START 2025ATLAS ENGINEERED PRODUCTS- WITH 99% OF BUSINESS COMING FROM CANADA, DIRECT EXPOSURE TO POTENTIAL ECONOMIC ACTIONS FROM U.S. IS REDUCEDSource te...Reuters
Mon, Feb 10
BRIEF-Vera Bradley Continues Board Refreshment With Appointment Of Andrew Meslow
Feb 10 (Reuters) - Vera Bradley VRA.O:VERA BRADLEY CONTINUES BOARD REFRESHMENT WITH APPOINTMENT OF ANDREW MESLOW, FORMER CEO OF BATH AND BODY WORKSSource text: ID:nGNXbv2lZDFurther company coverage: VRA.OReuters
Mon, Feb 10
BRIEF-Oxy Capital Purchase Additional Common Shares Of Montero Mining And Exploration
Feb 10 (Reuters) - Montero Mining and Exploration Ltd MON.V:OXY CAPITAL ANNOUNCES ADDITIONAL PURCHASES OF MONTERO MINING AND EXPLORATION LTD. COMMON SHARESOXY CAPITAL: ACQUIRED OWNERSHIP & CONTROL OF AN ADDITIONAL 1.02 MILLION COMMON SHARES OF MONTERO MINING AND EXPLORATION LTDSource text: ID:nC...Reuters
Mon, Feb 10
BRIEF-NXP Agrees To Acquire Edge AI Pioneer Kinara
Feb 10 (Reuters) - NXP Semiconductors NXPI.O:NXP AGREES TO ACQUIRE EDGE AI PIONEER KINARA TO REDEFINE THE INTELLIGENT EDGENXP SEMICONDUCTORS NV - DEAL VALUED AT $307 MILLION, EXPECTED TO CLOSE IN H1 2025Source text: ID:nGNX48Yw3BFurther company coverage: NXPI.OReuters
Mon, Feb 10
BRIEF-New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
Feb 10 (Reuters) - Radiopharm Theranostics RAD.AX:NEW CLINICAL TRIAL DATA HIGHLIGHTS RAD 101 (18F-PIVALATE) SUCCESSFULLY DETECTS BRAIN METASTASESSource text: ID:nGNX2bNwLDFurther company coverage: RAD.AXReuters
Mon, Feb 10
BRIEF-OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Feb 10 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ:OLIX AND LILLY ENTER GLOBAL LICENSING AGREEMENT FOR MASH AND OTHER CARDIOMETABOLIC INDICATIONSOLIX PHARMACEUTICALS INC - COLLABORATION TO DEVELOP AND COMMERCIALIZE OLX75016 FOR MASH AND CARDIOMETABOLIC INDICATIONSOLIX PHARMACEUTICALS INC - TO REC...Reuters
Mon, Feb 10
